2-5 October, 2018
Boston, MA

Accelerate the Development & Clinical Validation of Novel Predictive Biomarkers & Maximize the Commercial Viability of Diagnostic-Enabled Precision Medicines

The 9th Clinical Biomarkers & World CDx Boston Summit 2018 is once again the home for the biomarker, translational and diagnostic community to accelerate the translation from clinical biomarker into proven in vitro diagnostic. As the place to be for the precision medicine field, Clinical Biomarkers & World CDx Boston covers end-to-end the development, clinical implementation and commercialisation of a biomarker strategy to increase market penetration and market share for a targeted therapeutic. Ultimately, the meeting is here to streamline the path from R&D to providing patients with the right treatment decision and most effective therapies possible.

For biomarker, translational and clinical experts, Clinical Biomarker & World CDx Boston will help you bring novel predictive biomarkers to fruition, overcoming challenges in robust patient stratification and a demonstration of clinical utility to accelerate the approval of next generation precision medicines. For diagnostic and commercial leads, the meeting will provide insight into the maturation of disruptive technology, simultaneously tackling obstacles in reimbursement and commercialization to ensure the maximization of a diagnostic’s global footprint and implementation in healthcare.

The next event in our series will be held in London, UK in May 2018. For further information please click here.

The Clinical Biomarker & World CDx Boston Team are busy building the 2018 meeting right now. If you want to be involved or the first to know about the event, register your interest below.

button_register-your-interest (8)

“World CDx was a fantastic event both in terms of the science and the networking opportunities."

- Oscar Puig, Biomarker Leader, Oncology, Roche

Media Partner